SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stem Cell Research

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SnowShredder who wrote (426)4/4/2008 3:35:08 PM
From: SnowShredder   of 495
 
Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan

Message 24466373

Best of Luck,

SS

>>>>>>>>

<snip> "Enrollment was completed in a 20 patient investigator-initiated study in Japan using adipose-derived stem and regenerative cells in breast augmentation procedures. The study, which began November 2007, is evaluating a procedure whereby a woman's fat tissue is enriched with her own adipose derived stem and regenerative cells to create a natural filler. This technique is referred to as 'cell-enhanced reconstruction." <snip>

<snip>"Our clinic's goal for this study was to learn if cell-enhanced reconstruction is feasible for bilateral cosmetic breast augmentation as an alternative to implants," said Dr. Kamakura. "We look forward to assessing the procedure's effect on volume retention following the nine-month follow-up period as we believe that cell-enhanced reconstruction could overcome the challenges often associated with conventional, non-cell-enhanced fat grafting. We plan to continue offering cell-enhanced reconstruction to our patients in Tokyo and expand it to patients in our Osaka clinic as well." <snip>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext